Arabic Arabic English English French French German German
dark

KalGene Pharmaceuticals, Inc. announces a new peer-review publication demonstrating the efficacy of KG207 in clearing toxic oligomer species of amyloid beta in translational imaging studies

KalGene Pharmaceuticals, Inc. announced today a publication of a peer review article Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Departure of Founder and CEO Heightens Uncertainty for Galapagos

Next Post

Medivir receives regulatory approval from MHRA for phase 1/2a combination study with MIV-818

Related Posts
Total
0
Share